During the COVID-19 crisis, MedPharmics is firmly committed to continuing our services to the pharmaceutical industry. Specifically, this means that site staff are available to complete outstanding study items and/or communicate with CROs and sponsors. There is no time more relevant than our current situation for MedPharmics to continue to support clinical trials for tests, vaccines, and medications. Without clinical research, it would not be possible to develop new vaccines and treatments for diseases like COVID-19.
To date, no staff member at any site is exhibiting symptoms of infection. Furthermore, MedPharmics is not restricting CRA access to any of our facilities. If CROs prefer remote monitoring, we can also accommodate those requests. All sponsors and CROs will be immediately notified of any change in our status.